The Next 'Ozempic Moment' Could Be in Heart Disease
Just as Ozempic rewrote the obesity playbook, this breakthrough data could transform how we treat inflammatory heart disease. Fully funded. Multiple catalysts. $280B market opportunity.
| Open | 49.25 | Prev Close | 49.20 |
| High | 49.32 | Low | 49.15 |
| Volume | 13,157 | Volume (Avg) | 15,568 |
| 52 Week High | 61.00 | 52 Week Low | 42.38 |
| Market Cap | 100.2B | PE Ratio | 16.61 |
General
| Name | Bristol-Myers Squibb Co |
| Ticker | BMY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 34,100 |
About Bristol-Myers Squibb Co
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Highlights
| Analyst Target | 52.14 |
| Market Cap | 100,159,100,000 |
| PE Ratio | 16.61 |
| PEG Ratio | 2.26 |
| EBITDA | 19,217,000,448 |
Valuation
| Trailing PE | 16.57 |
| Forward PE | 8.13 |
| Price/Sales (Trailing 12 Mt.) | 2.09 |
| Price/Book (Most Recent Quarter) | 5.40 |
Technicals
| Beta | 0.30 |
| 52 Week High | 61.00 |
| 52 Week Low | 42.38 |
| 50 Day Average | 7.94% |
| 200 Day Average | 0.08% |
Dividend
Bristol-Myers Squibb Co pays out a dividend of $2.47 per share, with a dividend yield of 5.02%.
BMY's last dividend payment was made to shareholders on November 3, 2025.
They pay out 0.00% of their earnings out as a dividend.
Recent Dividends
| Nov 3, 2025 | $0.62 |
| Aug 1, 2025 | $0.62 |
| May 1, 2025 | $0.62 |
| Feb 3, 2025 | $0.62 |
| Nov 1, 2024 | $0.60 |
| Aug 1, 2024 | $0.60 |
| May 1, 2024 | $0.60 |
| Feb 1, 2024 | $0.60 |
Trump Has Some Tough Words For Marjorie Taylor Greene After Promising To 'Do Everything' He Can To Help Make Syria 'Successful'
Trump vows to make Syria successful after meeting with former al Qaeda commander, amid extended sanctions relief and GOP criticism.
Cathie Wood Dumps $2.4 Million Worth Of Tesla Stock, Doubles Down On These AI Stocks
Cathie Wood-led Ark Invest made significant trades involving Tesla, Pony AI, TSMC, and Baidu, highlighting their strategic positioning in tech & AI sectors.
Nvidia's Plan to Dominate the World of Robotics ... - Ad
Robots just had a coming-out party in Las Vegas. From household helpers to rescue bots, they're now essential-not just novelties. Forbes says it's a $24T opportunity. And Nvidia's CEO says one $7 stock is key to building the world's first trillion-dollar robot.
China's 'Singles' Day' shopping festival a gauge of Beijing's effort to get consumers to spend more
HONG KONG (AP) — Alice Zhang, a 29-year-old marketer in the southern Chinese city of Guangzhou, has spent only roughly half what she did last year during the festival, switching to cheaper choices and giving up on buying new shoes after pay was cut by more than 20%.
Noem Says National Guard Shooting Suspect Was Radicalized In US
DHS Secretary Kristi Noem says that the suspect in the fatal shooting of a National Guard member in Washington was radicalized domestically.
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
Chuck Schumer Says 41-Day Shutdown Has Exposed Trump's 'Cruelty,' Accuses President Of Holding Innocent Kids, Veterans As 'Political Hostages'
Schumer condemns Trump's 'cruelty' behind longest shutdown in U.S. history, as thousands of Americans suffer from furloughs and disrupted services.
Scaramucci Says This One US Mistake Helped China Become a Manufacturing Superpower
Anthony Scaramucci recently highlighted what he considers a significant error by the US that enabled China to ascend as a manufacturing superpower.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Paramount Skydance Stock Climbs After Q3 Report: Here's Why
Here's a look at the Q3 earnings report from Paramount Skydance.
Elon Musk Doubles Down On Solar-Powered AI Satellites, Predicts 'Convergence' Between Tesla, SpaceX, xAI — 'Tesla Is The World Leader In…'
Elon Musk shares plans for solar-powered AI satellites in orbit, touts Tesla as world leader and targets Optimus scale production next year.
Urgent Copper Stock With Strong Catalysts - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Adam Schiff Warns Trump Is Dragging America Toward A Venezuela War, Slams GOP For Treating Congress Like An 'Unnecessary Appendage'
Schiff warns that Trump's approach to Venezuela could lead to conflict and Congress must assert its power before it's too late.
Officer Injured By January 6 Predicts Trump Will Flee US After 2026 Elections: 'He'll Be Hopping on That Qatari Jet to Saudi Arabia'
Former District of Columbia Metro police officer Michael Fanone has speculated that President Trump might leave the U.S. after the 2026 elections.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Marjorie Taylor Greene Goes Bargain Shopping, Discloses Buying These Two Stocks At 52-Week Lows
Congresswoman Marjorie Taylor Greene disclosed some new stocks recently. Unlike past trades in 2024 and 2025, the latest disclosure is rather unique.
Ukrainian Naval Drones Cripple Two Russian Oil Tankers In Black Sea, Disrupt Moscow's Shadow‑Fleet Operations
Ukrainian naval drones struck 2 sanctioned tankers in Black Sea, critically damaging both and crippling a key Russian oil‑transport route.
Gold Alert: Extraordinary Upside in One Stock (Not a Miner) - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Trump attacks ABC News correspondent Mary Bruce in angry response to three sharp questions
NEW YORK (AP) — President Donald Trump denounced ABC News' Mary Bruce as a “terrible reporter” Tuesday and threatened the network's license to broadcast after she asked him three sharp questions at the White House.
Can Macy's Sustain Its Breakout As Q3 Earnings Loom?
With earnings approaching, it's important to evaluate where Macy's stands in its broader cycle and what the coming sessions may bring.
Nevada's Mining Renaissance Is Accelerating - And This Early Opportunity Is Well Positioned - Ad
Nevada's Walker Lane belt has produced 50M+ ounces of gold since the 1800s, and it's waking up again. One of the neighborhood's latest successes just secured over $6M in U.S. support and is up more than 300% YTD. Now a new early-stage explorer has moved in next door.
These are the 37 donors helping pay for Trump's $300 million White House ballroom
WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”
Warren Buffett Won't Buy Gold, And This Valuation Guru Agrees: 'It's A Collectible, Not An Asset'
Why don't Buffett & Damodaran buy gold? The valuation guru explains why gold is a 'collectible,' not an asset you can value.
New Number One Copper Start Alert - Ad
EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.
Elon Musk Says Tesla, xAI Are 'Trending Towards Convergence' In Some Ways
Elon Musk's companies could potentially merge in the future as he continues to integrate AI into his ventures.
Rand Paul Slams GOP's Shift From Fiscal Conservatism: They Voted To Add '$5 Trillion' To The Debt Ceiling — Calls It 'Decimation'
Sen. Rand Paul (R-Ky.) slammed the Republican Party for abandoning the fiscal discipline it once championed, while accusing his colleagues of embracing massive governmental deficits and greenlighting spending levels they previously opposed.
First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad
This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.
Movie Review: Time has outrun this 'Running Man'
It’s always interesting when time overtakes the dystopias of the past. In 1982 novel “The Running Man,” the United States has fallen into a totalitarian state, divided between haves and have-nots, where all movements can be surveilled and realistic video propaganda is easily generated. King’s book was set in the year 2025.
XRP Jumps 10% In A Week As First-Ever Spot ETF Eyes Thursday Launch
XRP (CRYPTO: XRP) surged 10% over the past seven days amid mounting anticipation for the first-ever XRP ETF, which could launch as early as this week.
The Next 'Ozempic Moment' Could Be in Heart Disease - Ad
Just as Ozempic rewrote the obesity playbook, this breakthrough data could transform how we treat inflammatory heart disease. Fully funded. Multiple catalysts. $280B market opportunity.
Watchdog group Public Citizen demands OpenAI withdraw AI video app Sora over deepfake dangers
The tech industry is moving fast and breaking things again — and this time it is humanity’s shared reality and control of our likeness before and after death — thanks to artificial intelligence image-generation platforms .
Jim Cramer's '10 Stocks To Own For The Future' In 2000 Cost This Redditor A Decade Of Retirement, Says Having To Work 10 More Years Was 'Painful'
A Reddit user slammed Jim Cramer's stock picks at the peak of the Dot-Com bubble, saying that the CNBC host's suggestions cost him a decade of retirement.
Nvidia's Plan to Dominate the World of Robotics ... - Ad
Robots just had a coming-out party in Las Vegas. From household helpers to rescue bots, they're now essential-not just novelties. Forbes says it's a $24T opportunity. And Nvidia's CEO says one $7 stock is key to building the world's first trillion-dollar robot.
Scaramucci Advocates For Market Solutions Amidst Rising Economic Challenges, Says 'People Like Mamdani Will Try And Use Socialist Means To Fix It'
Anthony Scaramucci emphasized the importance of market solutions to address societal issues, warning against potential socialist alternatives.
Silver Soars To Record Highs: It's Up 95% In 2025, The Best Year Since 1979
Silver prices surge over 5% as investors rush to secure metal amid tight supplies and global shortage concerns, driving up stocks and mining equities.
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
Donald Trump Administration's Unprecedented Investment In Private Firms Raises Eyebrows
President Trump administration has invested over $10 billion of taxpayer funds in private companies deemed crucial to national security.
Why 12-Year-Old Mark Zuckerberg Built A Little Messaging Network For The Family Member Who Reportedly Wrote Him $100,000 Check To Start Facebook
Preteen Mark Zuckerberg's early coding projects, including the family messaging system ZuckNet, combined with strong family support and a reported $100,000 check from his father, foreshadowed his creation of Facebook and Meta's later rise to a $1.54 trillion company.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
California revokes 17,000 driver's licenses. But the state disputes it is over immigration concerns
California plans to revoke 17,000 commercial driver’s licenses given to immigrants after the Trump administration raised concerns about people in the country illegally receiving licenses to drive a semitruck or a bus. But Gov. Gavin Newsom said that isn't the reason.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.